Schedule 13G ownership disclosure
Atossa Therapeutics Inc
Common Stock · CUSIP: 04962H506
Event date: 2025-06-30
- Filing-level shares
- 2,094,891
- Percent of class
- 1.6%
- BlackRock, Inc.
Shares: 2,094,891 · Class: 1.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002052113-25-002482
- Form type
- SCHEDULE 13G/A
- Filer
- ATOSSA THERAPEUTICS, INC.
- CIK
- CIK 1488039
- Filed
- Jul 16, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership